1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin has been researched along with arginine vasopressin in 28 studies
Studies (1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin) | Trials (1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin) | Recent Studies (post-2010) (1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
---|---|---|---|---|---|
28 | 0 | 0 | 12,278 | 422 | 1,212 |
Protein | Taxonomy | 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin (IC50) | arginine vasopressin (IC50) |
---|---|---|---|
Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (46.43) | 18.7374 |
1990's | 13 (46.43) | 18.2507 |
2000's | 2 (7.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T | 1 |
Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C | 1 |
Joran, ME; Murphy, DJ | 1 |
Campochiaro, PA; Delahunty, TM; Friedman, Z; Linden, J | 1 |
Campbell, GK; DiMartino, MJ; Gabel, RA; Hanna, N; Macia, RA; Silver, AC | 1 |
Brooks, VL; Hatton, DC | 1 |
Brooks, DP; Caldwell, N; Caltabiano, S; Huffman, WF; Kinter, LB; Winslow, C | 1 |
Holmes, MM; Lantos, I; Mendelson, WL; Tickner, AM | 1 |
Ashton, D; Dytko, G; Huffman, W; Kinter, LB; McDonald, J; Stassen, F | 1 |
Albrightson-Winslow, C; Brickson, B; Bryan, HG; Caldwell, N; Dytko, G; Eggleston, DS; Huffman, WF; Kinter, LB; Moore, ML; Newlander, KA | 1 |
Albrightson-Winslow, CR; Brooks, DP; Caldwell, N; Huffman, WF; Kinter, LB; Stassen, FL | 1 |
Ashton, N; Balment, RJ | 1 |
Garvie, CT; Rhodes, GR; Rubenfield, MJ | 1 |
Guyenet, PG; Sun, MK | 1 |
Berkowitz, BA; Ohlstein, EH | 1 |
Aiyar, N; Crooke, ST; Heckman, G; Landvatter, S; Nambi, P; Schmidt, D; Stassen, FL | 1 |
Aiyar, N; Crooke, ST; Nambi, P; Stassen, FL | 1 |
Albrightson, CR; Brooks, DP; Huffman, WF; Kinter, LB; Koster, PF; Stassen, FL; Wasserman, MA | 1 |
Kinter, LB; Liversidge, GG; Sternson, WL; Wilson, CG | 1 |
Albrightson-Winslow, CR; Brooks, DP; Huffman, WF; Kinter, LB; Koster, PF; Stassen, FL | 1 |
Holland, GA; Kinter, LB; Lenkinski, RE; Mattingly, MA; Sarkar, SK | 1 |
Aldasoro, M; Flor, B; Lluch, S; Martínez, MC; Medina, P; Vila, JM | 1 |
Bernardini, R; Chiarenza, A; Chrousos, GP; Demitrack, M; Gold, PW; Kamilaris, TC; Lempereur, L; Renaud, N | 1 |
Summerlee, AJ; Wilson, BC | 1 |
Divers, T; Huffman, WF; Kinter, LB; Monaghan, ML | 1 |
Caltabiano, S; Huffman, WF; Kinter, LB | 1 |
Antunes-Rodrigues, J; Branco, LG; Carnio, EC; Steiner, AA | 1 |
Angers, S; Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Laperrière, A; Lonergan, M; Morello, JP; Morin, D; Petäjä-Repo, U; Salahpour, A | 1 |
1 review(s) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and arginine vasopressin
Article | Year |
---|---|
Anomalous antidiuretic activity of antidiuretic hormone antagonists.
Topics: Animals; Arginine Vasopressin; Binding, Competitive; Deamino Arginine Vasopressin; Diuresis; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Receptors, Vasopressin; Species Specificity; Up-Regulation; Vasopressins | 1993 |
27 other study(ies) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and arginine vasopressin
Article | Year |
---|---|
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium | 1998 |
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance | 2000 |
Respiratory and cardiovascular changes associated with toxic doses of a peptide antagonist of vasopressin in the rat.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Male; Mast Cells; Peptides; Rats; Rats, Inbred Strains; Respiratory System; Vasopressins | 1992 |
Human retinal pigment epithelial cells possess V1 vasopressin receptors.
Topics: Aminoquinolines; Angiotensin Receptor Antagonists; Arginine Vasopressin; Calcium; Cells, Cultured; Cyclic AMP; Fluorescent Dyes; Humans; Inositol Phosphates; Pigment Epithelium of Eye; Receptors, Angiotensin; Receptors, Vasopressin; Spectrometry, Fluorescence; Vasopressins | 1991 |
Hypotension induced by vasopressin antagonists in rats: role of mast cell degranulation.
Topics: Animals; Arginine Vasopressin; Cell Degranulation; Edema; Hindlimb; Histamine Release; Hypotension; Male; Mast Cells; Rats; Rats, Inbred Strains; Time Factors; Vasopressins | 1990 |
Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Deamino Arginine Vasopressin; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Rate; Hypotension; Injections, Intravenous; Male; Nitroprusside; Norepinephrine; Receptors, Angiotensin; Receptors, Vasopressin; Sympathetic Nervous System; Vascular Resistance; Vasopressins | 1991 |
Physiological regulation of the renal vasopressin receptor-effector pathway in dogs.
Topics: Animals; Arginine Vasopressin; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Kidney; Osmolar Concentration; Receptors, Angiotensin; Receptors, Vasopressin; Vasopressins | 1990 |
Efficient solution phase synthesis of [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid)- 2-(O-ethyl-D-tyrosine)-4-valine-9-desglycine]arginine vasopressin.
Topics: Amino Acid Sequence; Arginine Vasopressin; Azides; Chemical Phenomena; Chemistry; Disulfides; Iodine; Molecular Sequence Data; Oligopeptides; Solutions; Sulfhydryl Compounds; Vasopressins | 1990 |
Discovery and therapeutic utility of vasopressin antagonists in rats.
Topics: Animals; Arginine Vasopressin; Dehydration; Diuresis; Dose-Response Relationship, Drug; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Shock, Septic; Vasopressins | 1986 |
A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity.
Topics: Adenylyl Cyclase Inhibitors; Amino Acid Sequence; Animals; Arginine Vasopressin; Binding, Competitive; Biological Assay; Blood; Chemical Phenomena; Chemistry; Dogs; Humans; Kidney Medulla; Molecular Conformation; Osmolar Concentration; Rats; Receptors, Angiotensin; Receptors, Vasopressin; Stereoisomerism; Structure-Activity Relationship; Swine; Urine; Vasopressins | 1989 |
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.
Topics: Animals; Arginine Vasopressin; Cyclooxygenase Inhibitors; Dinoprostone; Diuresis; Dogs; Dose-Response Relationship, Drug; Female; Indomethacin; Prostaglandins; Receptors, Angiotensin; Receptors, Vasopressin | 1989 |
Renal and blood pressure changes in response to vasopressin antagonism in the New Zealand genetically hypertensive rat.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Urination; Water-Electrolyte Balance | 1989 |
Determination of a disulfide-containing octapeptide antagonist of vasopressin in human plasma utilizing high-performance liquid chromatography with fluorescence detection.
Topics: Arginine Vasopressin; Chromatography, High Pressure Liquid; Humans; Spectrometry, Fluorescence | 1989 |
Effects of vasopressin and other neuropeptides on rostral medullary sympathoexcitatory neurons 'in vitro'.
Topics: Action Potentials; Adrenergic Fibers; Animals; Arginine Vasopressin; In Vitro Techniques; Medulla Oblongata; Neuropeptides; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin | 1989 |
Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists.
Topics: Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Kinetics; Mesenteric Arteries; Norepinephrine; Receptors, Angiotensin; Receptors, Vasopressin; Tachyphylaxis; Vasoconstriction | 1986 |
A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
Topics: Animals; Arginine Vasopressin; Binding, Competitive; Cell Line; Cell Membrane; Dogs; Guanylyl Imidodiphosphate; Kidney; Kinetics; Liver; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Receptors, Vasopressin | 1987 |
Effects of N-ethylmaleimide on arginine vasopressin-induced responses in an established smooth muscle cell line.
Topics: Animals; Aorta, Thoracic; Arginine Vasopressin; Calcium; Cell Membrane; Ethylmaleimide; GTP Phosphohydrolases; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Male; Muscle, Smooth, Vascular; Phosphatidylinositols; Rats | 1987 |
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Deamino Arginine Vasopressin; Disease Models, Animal; Flushing; Heart Rate; Hemodynamics; Indomethacin; Macaca mulatta; Male | 1988 |
Nasal delivery of a vasopressin antagonist in dogs.
Topics: Administration, Intranasal; Aerosols; Animals; Arginine Vasopressin; Biological Availability; Dogs; Dosage Forms; Female; Injections, Intravenous; Metabolic Clearance Rate; Nasal Cavity; Organometallic Compounds; Pentetic Acid; Technetium Tc 99m Pentetate | 1988 |
SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Dogs; Female; Humans; Kidney; Macaca mulatta; Natriuresis; Rats; Saimiri; Vasopressins | 1988 |
Renal imaging studies at 1.5 and 9.4 T: effects of diuretics.
Topics: Animals; Arginine Vasopressin; Diuretics; Furosemide; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Rats; Rats, Inbred Strains | 1988 |
Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
Topics: Adult; Arginine; Arginine Vasopressin; Deamino Arginine Vasopressin; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Indomethacin; Male; Mesenteric Arteries; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vasopressins | 1994 |
In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticotropin-Releasing Hormone; Hypothalamus; In Vitro Techniques; Injections, Intravenous; Kinetics; Male; Pituitary Gland; Rats; Rats, Sprague-Dawley | 1994 |
Effects of exogenous relaxin on oxytocin and vasopressin release and the intramammary pressure response to central hyperosmotic challenge.
Topics: Animals; Arginine Vasopressin; Female; Hypertonic Solutions; Lactation; Mammary Glands, Animal; Osmolar Concentration; Oxytocin; Pregnancy; Pressure; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Relaxin; Sodium Chloride; Stimulation, Chemical; Time Factors; Vasopressins | 1994 |
Antagonism of antidiuretic hormone in domestic pigs (Sus scrofa).
Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Diuresis; Drinking Behavior; Electrolytes; Female; In Vitro Techniques; Kidney Concentrating Ability; Kidney Medulla; Lypressin; Osmolar Concentration; Swine; Vasopressins | 1993 |
Role of nitric oxide in systemic vasopressin-induced hypothermia.
Topics: Animals; Arginine Vasopressin; Body Temperature; Body Temperature Regulation; Cerebral Ventricles; Hormone Antagonists; Hypothermia, Induced; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 1998 |
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Cell Line; Cell Membrane; COS Cells; Diabetes Insipidus, Nephrogenic; Flow Cytometry; Humans; Intracellular Fluid; Molecular Chaperones; Morpholines; Mutagenesis; Protein Folding; Pyrroles; Receptors, Vasopressin; Spiro Compounds | 2000 |